Chemotherapy Expert Forum
Gemzar fo Recurrent Ovarian Cancer
About This Forum:

Welcome to the International Chemotherapy forum. Questions related to lung cancer will be answered by a medical doctor.

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

Gemzar fo Recurrent Ovarian Cancer

My wife was diagnosed with stage III Ovarian cancer in July, 2002.  She underwent surgery and a regimen of chemo consisting of Taxol, Carboplatin, and Gemzar for seven treatments each.  In remission for six years then recurred August 2008.  Tried Taxol and Carboplatin for three treatments but reaction to Carbo and had to drop Carbo.  Stayed on Taxol for three more times and after ct scan found that of seven lymph tumors three had disappeared and four had shrunk substantially.  Now on only Gemzar for six treatments of which she has completed three.  Should she expect good results from this regimen?  She is now saying that whether tumors have/have not disappeared she wants to stop when finished.  She is unbelievably upbeat, always has been, but wants quality of life now without further drugs!
Related Discussions
322973_tn?1239908038
Hi,
Your wife had a good response to the Taxol, Carboplatin, gemcitabine combination chemotherapy in 2002 and was in remission for six years. Currently, the response to the Taxol also appears to be good. It is difficult to say how she will respond the Gemcitabine (Gemzar) alone. Since she has already completed three cycles with Gemcitabine, another reassessment with CA125 and CT scan may be done to measure the response and further treatment can be decided based on the results.
All the best, and God Bless!
Blank
Continue discussion Blank
MedHelp Health Answers
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
RSS Expert Activity
242532_tn?1269553979
Blank
How to Silence Your Inner Critic an...
Apr 16 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Emotional Eaters: How to Silence Yo...
Mar 26 by Roger Gould, M.D.Blank
1344197_tn?1392822771
Blank
Vaginal vs. Laparoscopic Hysterecto...
Feb 19 by J. Kyle Mathews, MD, DVMBlank